Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12475723rdf:typepubmed:Citationlld:pubmed
pubmed-article:12475723lifeskim:mentionsumls-concept:C0032821lld:lifeskim
pubmed-article:12475723lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:12475723lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:12475723lifeskim:mentionsumls-concept:C0205431lld:lifeskim
pubmed-article:12475723lifeskim:mentionsumls-concept:C0037509lld:lifeskim
pubmed-article:12475723lifeskim:mentionsumls-concept:C0056784lld:lifeskim
pubmed-article:12475723pubmed:issue1lld:pubmed
pubmed-article:12475723pubmed:dateCreated2002-12-11lld:pubmed
pubmed-article:12475723pubmed:abstractTextThe complexation of two steroid antibiotics of the fusidane family, sodium fusidate and potassium helvolate, by beta-CD and gamma-CD has been studied by using 1D and 2D-NMR techniques. Both guests form 1:1 complexes with gamma-CD and 1:2 (guest:cyclodextrin) complexes with beta-CD. Thus, both antibiotics behave as monotopic and ditopic guests when they are complexed by gamma-CD and beta-CD, respectively. Both steroids enter into the cavity of the gamma-CD by the side chain, reaching the central region of the steroid (rings C and D), whereas the A and B (partially) rings remain outside. For beta-CD complexes, ROESY spectra show a remarkable absence of interactions of the protons of the C and D rings, whereas clear interactions corresponding to the side chain, and A and B rings are observed. The obtained equilibrium constants (see previous paper) are discussed in terms of the structures proposed for the complexes. NMR spectra of sodium fusidate are revised, and a full assignment of the 1H and 13C NMR spectra is presented for potassium helvolate.lld:pubmed
pubmed-article:12475723pubmed:languageenglld:pubmed
pubmed-article:12475723pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:citationSubsetIMlld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12475723pubmed:statusMEDLINElld:pubmed
pubmed-article:12475723pubmed:monthJanlld:pubmed
pubmed-article:12475723pubmed:issn0039-128Xlld:pubmed
pubmed-article:12475723pubmed:authorpubmed-author:Al-SoufiWajih...lld:pubmed
pubmed-article:12475723pubmed:authorpubmed-author:YunesRosendo...lld:pubmed
pubmed-article:12475723pubmed:authorpubmed-author:JoverAidaAlld:pubmed
pubmed-article:12475723pubmed:authorpubmed-author:BudalRosane...lld:pubmed
pubmed-article:12475723pubmed:authorpubmed-author:MeijideFranci...lld:pubmed
pubmed-article:12475723pubmed:authorpubmed-author:Vázquez...lld:pubmed
pubmed-article:12475723pubmed:issnTypePrintlld:pubmed
pubmed-article:12475723pubmed:volume68lld:pubmed
pubmed-article:12475723pubmed:ownerNLMlld:pubmed
pubmed-article:12475723pubmed:authorsCompleteYlld:pubmed
pubmed-article:12475723pubmed:pagination55-64lld:pubmed
pubmed-article:12475723pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:meshHeadingpubmed-meshheading:12475723...lld:pubmed
pubmed-article:12475723pubmed:year2003lld:pubmed
pubmed-article:12475723pubmed:articleTitleSpectra and structure of complexes formed by sodium fusidate and potassium helvolate with beta- and gamma-cyclodextrin.lld:pubmed
pubmed-article:12475723pubmed:affiliationFacultad de Ciencias, Departamento de Química Física, Universidad de Santiago de Compostela, Campus de Lugo, Spain.lld:pubmed
pubmed-article:12475723pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12475723pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed